本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Humacyte, Inc.

1.45
-0.2300-13.69%
盘后1.480.0300+2.07%18:15 EDT
成交量:551.31万
成交额:819.92万
市值:2.25亿
市盈率:-1.16
高:1.66
开:1.64
低:1.44
收:1.68
数据加载中...
2024/09/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/03

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/08/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/13

重要事件披露

Form 8-K - Current report
2024/08/07

SEC问询函

Form CORRESP - Correspondence
2024/07/31

重要事件披露

Form 8-K - Current report
2024/06/13

重要事件披露

Form 8-K - Current report
2024/06/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/04

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/06/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]